Dr. Brodowski advises clients in connection with the protection and analysis of patent and other IP rights to support their business objectives. He has significant experience and knowledge in developing and evaluating patent portfolios including post-grant proceedings such as patent reexamination, reissue and foreign opposition proceedings. He analyzes patent landscapes to evaluate patentability and freedom-to-operate. Dr. Brodowski counsels on the Bayh-Dole Act and its impact on inventions made with federal government funding. He conducts IP due diligence for public and private business transactions; prepares patent opinions regarding infringement and invalidity; and advises on patent license and other technology-related agreements. He also assists patent litigation counsel.
Dr. Brodowski advises clients in a diverse range of technologies in the fields of chemistry including small molecules and pharmaceuticals, plastics and polymers, drug delivery technologies, specialty chemicals and chemical manufacturing; materials science and nanotechnology including composite materials; energy including petroleum processing, fuel cells, solar cells and biofuels; biotechnology; and health care including diagnostic assays, medical devices and personal care products.
Dr. Brodowski is a member of the Massachusetts Bar Association, the Boston Patent Law Association, and the American Chemical Society (Division of Chemistry and the Law).
Prior to joining Goodwin in 2016, he was a partner in the patent and IP practice groups at Burns Levinson LLP, K&L Gates LLP and Testa, Hurwitz & Thibeault LLP. Prior to entering the legal profession, Dr. Brodowski was a Project Chemist developing toiletries technology with The Gillette Company. He is the first named inventor on issued U.S. and foreign patents. His doctorate studies included the multistep synthesis of a macrolide antibiotic, chlorothricolide, starting with vitamin C.